---
title: Chlormezanone + Ibuprofen + Paracetamol
description: >-
  This combination medication is primarily prescribed for the relief of pain,
  inflammation, and muscle spasms associated with musculoskeletal conditions. 
  It combines the muscle relaxant properties of chlormezanone with the analgesic
  and anti-inflammatory effects of ibuprofen and paracetamol.
is_banned: false
lastModified: '2025-09-22T17:22:08.677Z'
faqs:
  - q: >-
      What is the recommended dosage for Chlormezanone + Ibuprofen +
      Paracetamol?**

      **A:** The dosage is determined by the physician based on the individual
      patient's needs and condition, considering the recommended dosages for
      each individual drug.
    a: >-
      A:** The dosage is determined by the physician based on the individual
      patient's needs and condition, considering the recommended dosages for
      each individual drug.
  - q: >-
      Can this combination be used during pregnancy?**

      **A:** It's generally avoided, especially during the third trimester. 
      Ibuprofen can cause premature closure of the ductus arteriosus in the
      fetus.
    a: >-
      A:** It's generally avoided, especially during the third trimester. 
      Ibuprofen can cause premature closure of the ductus arteriosus in the
      fetus.
  - q: >-
      What are the major drug interactions to be aware of?**

      **A:** Significant interactions include alcohol, anticoagulants, other
      NSAIDs, ACE inhibitors, and other CNS depressants.
    a: >-
      A:** Significant interactions include alcohol, anticoagulants, other
      NSAIDs, ACE inhibitors, and other CNS depressants.
  - q: >-
      What are the common side effects patients might experience?**

      **A:** Drowsiness, dizziness, nausea, gastrointestinal upset, and dry
      mouth.
    a: 'A:** Drowsiness, dizziness, nausea, gastrointestinal upset, and dry mouth.'
  - q: >-
      Are there any specific monitoring parameters for this combination?**

      **A:** Monitoring liver and renal function, and observing for signs of
      gastrointestinal bleeding are essential.
    a: >-
      A:** Monitoring liver and renal function, and observing for signs of
      gastrointestinal bleeding are essential.
  - q: >-
      Can this combination be used in patients with renal impairment?**

      **A:** Use with caution and dose adjustment may be necessary in patients
      with renal impairment.
    a: >-
      A:** Use with caution and dose adjustment may be necessary in patients
      with renal impairment.
  - q: >-
      Is this combination suitable for long-term use?**

      **A:** Long-term use should be carefully considered and monitored due to
      the potential for gastrointestinal and renal adverse effects, particularly
      with ibuprofen.
    a: >-
      A:** Long-term use should be carefully considered and monitored due to the
      potential for gastrointestinal and renal adverse effects, particularly
      with ibuprofen.
  - q: >-
      What should be done in case of an overdose?**

      **A:**  Seek immediate medical attention. Supportive care and management
      of specific symptoms are crucial.
    a: >-
      A:**  Seek immediate medical attention. Supportive care and management of
      specific symptoms are crucial.
  - q: >-
      How does chlormezanone contribute to this combination?**

      **A:** It provides muscle relaxation, which can be beneficial in
      musculoskeletal conditions where muscle spasms accompany pain and
      inflammation.
    a: >-
      A:** It provides muscle relaxation, which can be beneficial in
      musculoskeletal conditions where muscle spasms accompany pain and
      inflammation.
---
## **Usage**

This combination medication is primarily prescribed for the relief of pain, inflammation, and muscle spasms associated with musculoskeletal conditions.  It combines the muscle relaxant properties of chlormezanone with the analgesic and anti-inflammatory effects of ibuprofen and paracetamol.

**Pharmacological Classifications:**

* **Chlormezanone:** Centrally acting muscle relaxant, anxiolytic
* **Ibuprofen:** Nonsteroidal anti-inflammatory drug (NSAID)
* **Paracetamol:** Analgesic, antipyretic

**Mechanism of Action:**

Chlormezanone acts centrally to reduce muscle spasms.  Ibuprofen inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis and thereby decreasing pain and inflammation. Paracetamol's mechanism is not fully understood, but it is believed to inhibit COX enzymes primarily in the central nervous system, providing analgesic and antipyretic effects.


## **Alternate Names**

This specific combination doesn't have an international nonproprietary name (INN).  It is often identified by the names of its constituents. Brand names may vary regionally.


## **How It Works**

**Pharmacodynamics:**

Chlormezanone depresses polysynaptic reflexes in the spinal cord and possibly at supraspinal sites, leading to muscle relaxation. Ibuprofen and paracetamol reduce pain and fever by inhibiting prostaglandin synthesis.

**Pharmacokinetics:**

* **Chlormezanone:**  Metabolized in the liver and excreted primarily in the urine.
* **Ibuprofen:** Absorbed from the gastrointestinal tract, extensively metabolized in the liver, and excreted in the urine.
* **Paracetamol:**  Absorbed rapidly from the gastrointestinal tract, metabolized in the liver, and excreted in the urine, primarily as glucuronide and sulfate conjugates.

**Mode of Action:**

Chlormezanone acts by enhancing GABAergic transmission, though the specific mechanism is not completely elucidated. Ibuprofen and paracetamol inhibit COX-1 and COX-2 enzymes.

**Elimination Pathways:** Primarily renal excretion for all three components.


## **Dosage**


### **Standard Dosage**

#### **Adults:**

Chlormezanone: 100-200mg three times daily.
Ibuprofen: 400mg every 4-6 hours as needed, not exceeding 3200mg/day.
Paracetamol: 500-1000mg every 4-6 hours as needed, not exceeding 4000mg/day.

*The combination dosage should be determined and adjusted by a physician based on the individual patient's needs and tolerance.*

#### **Children:**

Dosage should be determined by a physician and based on weight and age, considering the individual components.

#### **Special Cases:**

* **Elderly Patients**: Initiate with lower doses and monitor closely.
* **Patients with Renal Impairment**: Dose adjustment may be necessary.
* **Patients with Hepatic Dysfunction**:  Dose adjustment may be necessary.
* **Patients with Comorbid Conditions**: Careful consideration and potential dose adjustment are required based on the specific comorbidity.



### **Clinical Use Cases**

The use of this combination in specific clinical settings like intubation, surgical procedures, or ICU would be determined on a case-by-case basis by the treating physician. It's not routinely indicated for these scenarios.


### **Dosage Adjustments**

Adjustments are based on individual patient characteristics, renal and hepatic function, and response to therapy.


## **Side Effects**


### **Common Side Effects**

Drowsiness, dizziness, nausea, dry mouth, constipation (with chlormezanone). Gastrointestinal upset, headache, dizziness (with ibuprofen).


### **Rare but Serious Side Effects**

Allergic reactions, Steven-Johnson syndrome, hepatotoxicity (with paracetamol and ibuprofen), blood disorders (with ibuprofen).


### **Long-Term Effects**

Gastrointestinal bleeding, renal impairment (with ibuprofen).


### **Adverse Drug Reactions (ADR)**

Severe skin reactions, anaphylaxis, acute liver failure.


## **Contraindications**

Hypersensitivity to any of the components. Severe hepatic or renal impairment. Aspirin triad.  Pregnancy (especially third trimester for ibuprofen).


## **Drug Interactions**

Alcohol, anticoagulants, other NSAIDs, ACE inhibitors, lithium, methotrexate, other CNS depressants.


## **Pregnancy and Breastfeeding**

Generally avoided during pregnancy, especially the third trimester. Consult a physician regarding breastfeeding.



## **Drug Profile Summary**

* **Mechanism of Action:**  Centrally acting muscle relaxation (chlormezanone), COX inhibition (ibuprofen and paracetamol).
* **Side Effects:**  Drowsiness, dizziness, gastrointestinal upset, potential for hepatotoxicity.
* **Contraindications:** Hypersensitivity, severe hepatic/renal impairment, aspirin triad, pregnancy.
* **Drug Interactions:** Alcohol, anticoagulants, NSAIDs, ACE inhibitors.
* **Pregnancy & Breastfeeding:** Generally avoided.
* **Dosage:**  Individually determined by physician.
* **Monitoring Parameters:**  Liver function tests, renal function tests, signs of gastrointestinal bleeding.


## **Popular Combinations**

This specific combination is not a standard or widely recognized fixed-dose combination. Individual components may be combined with other medications based on clinical needs.



## **Precautions**

Standard precautions related to each individual drug apply. Evaluate hepatic and renal function. Screen for allergies.  Avoid alcohol.


## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Chlormezanone + Ibuprofen + Paracetamol?**
**A:** The dosage is determined by the physician based on the individual patient's needs and condition, considering the recommended dosages for each individual drug.

### **Q2: Can this combination be used during pregnancy?**
**A:** It's generally avoided, especially during the third trimester.  Ibuprofen can cause premature closure of the ductus arteriosus in the fetus.

### **Q3: What are the major drug interactions to be aware of?**
**A:** Significant interactions include alcohol, anticoagulants, other NSAIDs, ACE inhibitors, and other CNS depressants.

### **Q4:  What are the common side effects patients might experience?**
**A:** Drowsiness, dizziness, nausea, gastrointestinal upset, and dry mouth.

### **Q5: Are there any specific monitoring parameters for this combination?**
**A:** Monitoring liver and renal function, and observing for signs of gastrointestinal bleeding are essential.

### **Q6: Can this combination be used in patients with renal impairment?**
**A:** Use with caution and dose adjustment may be necessary in patients with renal impairment.

### **Q7:  Is this combination suitable for long-term use?**
**A:** Long-term use should be carefully considered and monitored due to the potential for gastrointestinal and renal adverse effects, particularly with ibuprofen.

### **Q8: What should be done in case of an overdose?**
**A:**  Seek immediate medical attention. Supportive care and management of specific symptoms are crucial.


### **Q9:  How does chlormezanone contribute to this combination?**
**A:** It provides muscle relaxation, which can be beneficial in musculoskeletal conditions where muscle spasms accompany pain and inflammation.

